⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Extracellular Vesicles in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-15 — Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.: Mouse cardiac-aging study [animal-model] reports improved cardiac function after human umbilical cord MSC-derived exosome treatment alongside AMPKα2-associated lysine β-hydroxybutyrylation remodeling, extending the vesicle-mediated metabolic-regulation narrative without establishing efficacy or safety of exosome therapies for human cardiac aging. [animal-model] (novelty: 3)
- 2026-10-01 — Endothelial TLR4 at the Crossroads of Vascular Senescence and Targeted Senotherapeutics.: cross-connection with endothelial-tlr4-vascular-senescence: Engineered plant exosomes are nominated as a delivery vehicle for endothelial TLR4 inhibition, pulling EV biology into the targeted-senotherapy delivery conversation. (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: cross-connection with circulating-senosome: Extracellular vesicles are nominated as a core carrier compartment of the senosome, tying EV-aging biology to the broader blood-interface integration. (novelty: 3)
- 2026-09-23 — Extracellular Vesicles From Senescent Cancer Cells Are Necessary and Sufficient to Drive Paracrine Senescence: Preclinical study upgrades the senescent-cell EV signal from correlative cargo profiling to a necessary-and-sufficient paracrine senescence-transmission carrier in a cancer-cell context, sharpening the causal role of EVs in bystander spread. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.
15-oct-2026
novelty 3
per-area 3
strengthens
The Role of EVs in the Aging Hematopoietic System.
01-oct-2026
novelty 2
per-area 3
introduces
Extracellular Vesicles From Senescent Cancer Cells Are Necessary and Sufficient to Drive Paracrine Senescence
23-sep-2026
novelty 3
per-area 3
strengthens
The Role of EVs in the Aging Hematopoietic System
23-sep-2026
novelty 2
per-area 2
introduces